Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles
R Imperial, Z Ahmed, OM Toor, C Erdoğan, A Khaliq… - Molecular cancer, 2018 - Springer
Right-sided colon cancer (RCC) has worse prognosis compared to left-sided colon cancer
(LCC) and rectal cancer. The reason for this difference in outcomes is not well understood …
(LCC) and rectal cancer. The reason for this difference in outcomes is not well understood …
[HTML][HTML] Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis
H Yu, Q Liu, K Wu, S Tang - Clinical and Experimental Medicine, 2024 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are approved to treat colorectal cancer (CRC) with
mismatch-repair gene deficiency, but the response rate remains low. Value of current …
mismatch-repair gene deficiency, but the response rate remains low. Value of current …
[PDF][PDF] Identifying common mutations in colorectal cancer using a 7-gene panel by next generation sequencing
CB Lee, YW Kien, N Dusa… - Malays. J. Med …, 2019 - medic.upm.edu.my
Introduction: Colorectal cancer (CRC) arises from the cumulative effects of genetic and
epigenetic alterations. Current treatment of metastatic CRC relies on combination of …
epigenetic alterations. Current treatment of metastatic CRC relies on combination of …